Human Para is a nonprofit committed to funding research and providing information about the role of Mycobacterium paratuberculosis (MAP) in immune conditions.
@cryptowriterxby @SabinehazanMD@Progenabiome Here's a new paper which you may find interesting. Journal link is at the bottom of the post. https://t.co/V9SAgVx0xe
Prof. Hermon-Taylor will always have a special place in my heart for all he did for MAP research. The world has lost an amazing man, and I am forever grateful that he had the courage to blaze a trail for us all. #MAP2CURE
https://t.co/3D9heYy3fN
See what's new in the world of Human Para and MAP research! Lots of key articles this quarter, including a publication from the vaccine group and 2 new articles on phages. Plus a 2021 meta-analysis of antibiotics in Crohn's disease. #MAP2CURE
https://t.co/2XcA4aLC1L
Congrats to this amazing team of researchers who donated their time and expertise for Human Para's inaugural research study! Lots of MAP in lots of people. #MAP2CURE
Presence of Infection by Mycobacterium avium subsp. paratuberculosis in the Blood of Patients with Crohn's Disease and Control Subjects Shown by Multiple Laboratory Culture and Antibody Methods. https://t.co/yBRPVIomZ6
@paintthegirl Not a repeat of this, but there is development being done on many of these methods in this study by the individual researchers. Human Para just sponsored a new study on susceptibility of MAP strains to different abx though!
@paintthegirl Agreed - but there are no “historical” methods of detecting MAP specifically in humans. This is an excellent starting point that we can build on in the future with more research!
Meet Dr. Nicole Parrish. Human Para is funding her research to determine which antibiotic combos are most effective against MAP. In 2017 she presented this research showing MAP can survive by converting to an anaerobic state under stress. #MAP2CURE
https://t.co/HrnI1pYoXa
Help us fund our latest MAP research project this Giving Tuesday. 100% of your donation goes directly to MAP research!! #MAP2CURE https://t.co/pvuw2MA7so
Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn's Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection. https://t.co/f0AA1xjmq5
Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn's Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection. https://t.co/f0AA1xjmq5